Twist Bioscience Corporation (TWST) Tops Q4 EPS by 12c; offers guidance

Twist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.59), $0.12 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $84.71 million versus the consensus estimate of $82.74 million.

GUIDANCE:

Twist Bioscience Corporation sees Q1 2025 revenue of $87 million, versus the consensus of $84.269 million.

Twist Bioscience Corporation sees FY2025 revenue of $367-377 million, versus the consensus of $310.8 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• JPM identifies consumer sectors to buy for a 2H rebound
• Buy gold stocks as valuations are cheap amid macro tension: BofA